Production & Manufacturing
Production & Manufacturing
Impax, Perrigo to jointly develop topical generic drug
Impax Laboratories and Perrigo Company have signed a deal to develop and manufacture an undisclosed topical generic drug. The terms of the deal that also involves marketing of the extended topical generic product were...
Production & Manufacturing
Fujifilm to manufacture bulk substance for ThromboGenics’ eye medication
Fujifilm Diosynth Biotechnologies will manufacture the bulk substance for ThromboGenics' FDA approved Jetrea (ocriplasmin) indicated for symptomatic vitreomacular adhesion (VMA). The companies signed a long-term supply agreement in September 2010 and worked towards completing...
Production & Manufacturing
Mylan Labs to buy SMS Indian manufacturing unit
Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m). The manufacturing unit was designed for the production of cancer medications and...
Production & Manufacturing
Biostar to manufacture, supply five additional drugs to Xijing Hospital
Biostar Pharmaceuticals has entered into an agreement worth $3m to manufacture and supply five additional drugs to Xijing Hospital for one-year. The five drugs include Qing Wen Granule, Ru Xiao Kang Capsule, Stomach and...
Production & Manufacturing
Pfizer joins forces with Mylan for generic drugs development
Pfizer and Mylan have entered into a collaboration agreement to develop, manufacture, distribute and market generic drugs in Japan. Under the agreement, Pfizer will take responsibilities for the commercialization of the combined generics portfolio,...
Production & Manufacturing
Alexza Adasuve manufacturing facility wins EU Certificate of GMP Compliance
Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility. In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de...
Production & Manufacturing
Tris Pharma completes first phase of manufacturing expansion
Tris Pharma has initiated an expansion of its manufacturing capacity earlier in 2012 and is roughly midway through a 15 month expansion. The expansion will take the company's footprint from its current 90,000ft² to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
